IVERIC bio (ISEE) Tops Q3 EPS by 5c

IVERIC bio (NASDAQ: ISEE) reported Q3 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Ecolab pops as Citi sees improving setup into Q2 earnings
• Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq